SELECTIS HEALTH, INC.
GBCSOTCReal Estate · Real Estate Investment Trusts · UT · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $41.4M | $39.5M | $36.8M | $40.6M | $29.3M | $20.9M |
| Operating income | −$1.6M | −$2.7M | −$9.0M | −$286,572 | −$728,992 | $3.4M |
| Net income | −$1.0M | −$2.4M | −$4.0M | −$2.4M | −$2.3M | $3.0M |
| Total assets | $32.6M | $33.4M | $40.7M | $42.5M | $46.9M | $45.9M |
| Total liabilities | $38.8M | $38.9M | $43.6M | $41.5M | $43.8M | $42.7M |
| Equity | −$6.2M | −$5.4M | −$3.0M | $952,835 | $3.1M | $3.4M |
| EPS (diluted) | $-0.34 | $-0.80 | $-1.31 | $-0.79 | $-0.82 | $0.95 |
| Shares out. | 3.1M | 3.1M | 3.1M | 3.1M | 26.9M | 27.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3.8%
- Net margin
- −2.5%
- Return on equity
- 16.4%
- Return on assets
- −3.1%
- Return on capital (ROCE)
- −21.4%
- Liabilities / assets
- 119.1%
- Debt / equity
- —
- Book value / share
- $-2.02
- Revenue growth (YoY)
- 4.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -6.18distress
- Accruals / assets
- −8.9%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 3 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 14, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Q/Amissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 13, 2026 | 99 | 1.0 | +100.0% |
| Sep 15, 2025 | 261 | 1.0 | +31.2% |
| Aug 29, 2025 | 199 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 20, 2026
- Completed an acquisition or dispositionMay 7, 2026
- Director / officer changeMar 31, 2026
- Director / officer changeMar 19, 2026
- Entered a material agreementMar 9, 2026
- Completed an acquisition or dispositionJan 21, 2026
- Director / officer changeJan 6, 2026
- New financial obligation · Modified shareholder rightsDec 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 3May 26, 2026
- 10-QMay 22, 2026
- 8-KMay 20, 2026
- NT 10-QMay 14, 2026
- 8-KMay 7, 2026
- SC TO-T/AAMENDMENT NO. 2 TENDER OFFERMay 1, 2026
- 10-KApr 15, 2026
- 8-KMar 31, 2026
- NT 10-KMar 31, 2026
- SC 14D9Mar 25, 2026
- 5/AMar 23, 2026
- 8-KMar 19, 2026
- SC TO-T/AAMENDMENT NO. 1 TO TENDER OFFERMar 13, 2026
- 5Mar 12, 2026
- SC TO-TTENDER OFFER STATEMENT BY A THIRD PARTYMar 10, 2026